Novo Nordisk A/S
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| NVO | 0QYQ.IL | NVS | LLY | BIIB.MX | 0NZU.IL | |
|---|---|---|---|---|---|---|
| Market cap | 185.98B | 219.86B | 311.59B | 1.26T | 693.22B | 14.42B |
| P/E (TTM) | 10.7 | 40.6 | 31.5 | 46.0 | 115.0 | — |
| Forward P/E | 12.3 | — | 16.6 | 28.3 | — | — |
| Price/book | 5.7 | 10.4 | 8.4 | 31.4 | 2.0 | 8.2 |
| Dividend yield | 4.26% | 3.81% | 2.87% | 0.49% | — | — |
| 1-year change | −9.31% | +40.64% | +30.35% | +51.26% | +68.09% | −43.38% |
| Today | +4.95% | +2.59% | +3.59% | +0.61% | 0.00% | +1.45% |
The closest companies by business and industry (Drug Manufacturers - General). Prices may be delayed up to 20 min.
Latest news
All NVO news ›Novo Nordisk Stock Jumped After Earnings — But Its CEO Won't Give 2027 Guidance. Here's What Investors Should Know
Novo Nordisk raised its 2026 outlook for the second time in three months, and the stock jumped about 5% on Wednesday. CEO Mike Doustdar wouldn't forecast 2027, but he listed three things helping next year's sales and three hurting them. A…
GENFIT’s (Euronext: GNFT) MASH Diagnostic Tool Draws Novo Nordisk, Eli Lilly And Madrigal As Medicare Coverage Milestone Reshapes Treatment Landscape
By David Prior | Nov 4, 2026 | Economy & Business, Featured, News & Analysis With Medicare reimbursement for its NASHnext® test having taken effect in August, GENFIT finds itself at the center of a rapidly shifting commercial landscape for…
De Novo Bank Filings Surge as Fintechs Seek Bigger Slice of Financial Pie
Law.com De Novo Bank Filings Surge as Fintechs Seek Bigger Slice of Financial Pie "The current push for new charters has a lot to do with tech companies that view banking as a way to access certain processes," said banking co
European shares jump over 1% after Democrats sweep US Congress, Novo Nordisk surges
By Johann M Cherian and Avinash P Nov 4 (Reuters) - The European equity benchmark closed at a more than two-month high on Wednesday in broad-based gains after Democrats won control of both chambers of the US Congress, while Wegovy maker…
More from 1 other outlet
Novo Nordisk Stock Jumps 6% as Wegovy Hits a Stunning 80% Milestone
Novo Nordisk shares surged Wednesday on a single metric from the Wegovy earnings call that suggested the oral pill is reshaping the obesity market faster than Wall Street expected, even as prices fall and a rival closes in. Novo Nordisk…
Novo Surges 5% After Walloping Expectations On The Back Of Its GLP-1 Drugs
Allison Gatlin covers biotechnology, pharmaceuticals and medical technology. She also oversees coverage of top-performing companies for Investor's Business Daily's The New America page. Allison has worked for Investor's Business Daily…
Novo Nordisk hikes 2026 outlook again as Wegovy pill beats forecasts
By Jacob Gronholt-Pedersen and Patrick Wingrove COPENHAGEN, Nov 4 (Reuters) - Obesity drugmaker Novo Nordisk raised its 2026 outlook for the third time this year on Wednesday as quarterly sales of its Wegovy pill beat forecasts, bolstering…
More from 1 other outlet
Novo Nordisk (NVO) Q3 2026 Earnings Call Transcript
Wegovy pill uptake and CagriSema trial results shape the growth recovery story. Wed, Nov. 4, 2026 Operator: Please stand by while the speakers reconnect. Please stand by while the speakers reconnect. Michael Novod: Do not know where we got…
More from 1 other outlet
Miami Celebrates 25 Years of the NOVO Awards!
Miami’s Community News Miami Celebrates 25 Years of the NOVO Awards! Connect To Your Customers & Grow Your Business Grant can be reached at [email protected]
Novo hikes outlook again as it speeds up Wegovy pill rollout
The logo of pharmaceutical company Novo is displayed in front of its offices in Bagsvaerd, Copenhagen, Denmark, November 3, 2026. REUTERS/Tom Little A blister pack containing Wegovy (semaglutide) tablets on a line in Novo Nordisk’s…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- marketscreener.com70
- fool.com17
- theglobeandmail.com17
- foreignpolicyjournal.com13
- medwatch.com13
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 120 articles, not a forecast.